Nevirapine Morningside

Nevirapine, the active ingredient in Nevirapine Morningside, is a Non-nucleoside reverse transcriptase inhibitor (NNRTI) presented as a tablet for oral use. It treats HIV-1 infection in adults and children, helping to suppress viral replication and improve immune function.

GNH USA supplies Nevirapine Morningside as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nevirapine is an antiretroviral medication used to manage HIV‑1 infection, either alone or as part of combination therapy. - Adult HIV‑1 infection: reduces viral load and improves immune function. - Pediatric HIV‑1 infection: helps control viral replication in children. - Combination antiretroviral therapy: used as part of HAART to achieve sustained virologic suppression.

Nevirapine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Rash: mild to moderate skin eruptions. - Nausea: occasional upset stomach. - Fatigue: feeling of tiredness. - Headache: mild to moderate. - Dizziness: transient light‑headedness. - Abdominal pain: discomfort in the stomach area.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction. - Hepatic failure: significant liver injury. - Severe hypersensitivity: systemic allergic response. - Neutropenia: low white‑blood‑cell count. - Liver toxicity: elevated transaminases. - Life‑threatening skin reactions: toxic epidermal necrolysis.

Before prescribing Nevirapine, clinicians should consider several safety measures. - Liver function monitoring: assess baseline enzymes and repeat regularly. - Rash assessment: discontinue if severe or progressing. - Drug interaction review: avoid concurrent use with strong CYP inducers. - Pregnancy considerations: use only when benefits outweigh risks (Category B). - Hepatic impairment adjustment: dose may need modification. - Store at room temperature: keep in the original pack, protect from moisture.

Nevirapine interacts with several medicines, requiring careful management.

Major Interactions (Avoid): - Rifampicin: markedly reduces nevirapine levels. - St. John’s wort: induces metabolism, lowering efficacy. - Protease inhibitors (e.g., ritonavir): can increase toxicity.

Moderate Interactions (Monitor Closely): - Azole antifungals: may increase nevirapine concentrations. - Macrolide antibiotics: potential for altered plasma levels. - Warfarin: monitor INR for anticoagulation changes.